GTS Securities’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-15,100
Closed -$418K – 4359
2023
Q3
$418K Buy
+15,100
New +$448K ﹤0.01% 2792

Other funds holding RVMD

GTS Securities's RVMD Position: Q3 2026 in Review

GTS Securities sold out of Revolution Medicines (RVMD) in Q3 2026, closing a stake of 1,151 shares — an estimated $216K sold.

GTS Securities first reported a position in RVMD in Q2 2026 and held it in 1 quarter. The position peaked at $216K in Q2 2026. 756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • GTS Securities reported no remaining Revolution Medicines position as of Q3 2026 after selling out during the quarter.
  • GTS Securities sold 1,151 Revolution Medicines shares in Q3 2026, an estimated $216K.
  • GTS Securities first reported a position in Revolution Medicines in Q2 2026 and held it in 1 quarter.
  • GTS Securities's Revolution Medicines position peaked at $216K in Q2 2026.
  • 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.